02.22.21

Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations

Source: Bausch Health

02.15.21

Icahn to Push for Changes at Bausch Health After Disclosing Stake

Source: FirstWord

02.09.21

Bausch Health Announces Vyzulta is Now Approved in South Korea

Source: Bausch Health

11.16.20

B+L: Investigational In Vitro Data Indicates Complete Inactivation Of SARS-CoV-2 With Lumify and Besivance Eye Drops

Source: Bausch Health

10.15.20

Bausch Health and BHVI Announce Global Licensing Agreement For Myopia Control Contact Lens

Source: Bausch Health

10.12.20

Bausch Health Licenses Eyenovia’s Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12

Source: Bausch Health

09.25.20

FDA Approves Bausch + Lomb Alaway Preservative Free OTC Drops

Source: Bausch Health

09.24.20

Bausch Health Announces Vyzulta Now Approved in Seven Countries; Expanded Coverage in Canada

Source: Bausch Health

09.21.20

Bausch Health Acquires Option To Purchase Ophthalmology Assets Of Allegro Ophthalmics

Source: Bausch Health

04.28.20

Clearside Biomedical Revises NDA Resubmission Timeline and Xipere Commercial Partnership with Bausch Health

Source: Clearside Biomedical

View more stories